Citations 2
Real-world Improvements in Cognitive Symptoms After Eptinezumab Treatment in Patients in Whom ≥1 Prior Anti-CGRP Preventive Treatment had Failed: 6-month Results for the Ongoing INFUSE Study (P1-15.006)
Estemalik, Emad, Lipton, Richard, Soni-Brahmbhatt, Seema , Regnier, Stephane, Awad, Susanne, Grossman, S. Wald , Townshend, Michelle, Starling, Amaal, Régnier, Stéphane A. , Awad, Susanne F. , Grossman, S. Wald
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
Reasons for Discontinuing Triptans Among Current Users of Rimegepant for the Acute Treatment of Migraine in the CONFIDENCE Study (P8-15.018)
Lipton, Richard, Goadsby, Peter; id_orcid 0000-0003-3260-5904, Pozo-Rosich, Patricia, Schwedt, Todd, Fanning, Kristina, Abraham, Lucy, Blakeman, Karin Hygge , Urani, Alexandre , Lambru, Giorgio , Pozo‐Rosich, Patricia , Schwedt, Todd J. , Fanning, Kristina M. , Dai, Feng , Abraham, Lucy
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available